Workflow
Haploinsufficient Diseases
icon
搜索文档
Stoke Therapeutics (NasdaqGS:STOK) FY Conference Transcript
2025-11-11 23:00
Stoke Therapeutics (NasdaqGS:STOK) FY Conference November 11, 2025 09:00 AM ET Speaker0All right. Good morning, everyone. Welcome to Guggenheim Healthcare Innovation Conference. My name is Yathin Suneja, one of the biotech analysts here at Guggenheim. It is my pleasure to welcome our next presenting company, Stoke Therapeutics. From the company, we have the Chief Executive Officer, Ian Smith, who recently became full-time CEO from an interim CEO. Thank you, Ian, for joining us. Why don't you make some openi ...